IMMUNOGENICITY AND SAFETY PROFILES OF GENETIC VACCINES AGAINST HUMAN HER-2/NEU IN CYNOMOLGUS MONKEYS

被引：0
|
作者：
Ko, Hyun-Jeong [1 ]
Kim, Yeon-Jeong [1 ]
Kim, Yun-Sun [1 ]
Kim, Jong-Mook [2 ]
Ho, Seong-Huyn [2 ]
Jeong, Jae-Gyun [2 ]
Oh, Sung-Min [2 ]
Chae, Jin-A [2 ]
Kim, Choong-Yong [3 ]
Lee, Pill Soo [3 ]
Kang, Chang-Yuil [1 ]
机构：
[1] Seoul Natl Univ, Coll Pharm, Inst Pharmaceut Sci, Immunol Lab, Seoul 151742, South Korea
[2] ViroMed Co Ltd, Seoul 151818, South Korea
[3] Korea Inst Toxicol, Div Nonclin Studies, Taejon 305600, South Korea
来源：
JOURNAL OF GENE MEDICINE | 2009年 / 11卷 / 12期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：1190 / 1190
页数：1
相关论文
共 50 条
  • [41] In the FVB/N HER-2/neu transgenic mouse both peripheral and central tolerance limit the immune response targeting HER-2/neu induced by Listeria monocytogenes-based vaccines
    Reshma Singh
    Yvonne Paterson
    Cancer Immunology, Immunotherapy, 2007, 56 : 927 - 938
  • [42] Expression of HER-2/neu splice variants in the human breast cancer cells
    Arai, C.
    Miura, T.
    Kasai, K.
    Chiba, M.
    Nozaka, H.
    Kazama, R.
    Muramatsu, A.
    Sato, T.
    MODERN PATHOLOGY, 2008, 21 : 19A - 20A
  • [43] Expression of HER-2/neu splice variants in the human breast cancer cells
    Ambaye, A. B.
    Goodwin, A.
    MacLennan, S. E.
    Aloud, S.
    Fleaver, D. L.
    LABORATORY INVESTIGATION, 2008, 88 : 19A - 20A
  • [44] Isolation of a novel nanobody against HER-2/neu using phage display technology
    Sheikholeslami, F.
    Rasaee, M. J.
    Shokrgozar, M. A.
    Dizaji, M. Mokhtari
    FEBS JOURNAL, 2010, 277 : 43 - 43
  • [45] EXPRESSION OF THE HER-2/NEU PROTOONCOGENE IN NORMAL HUMAN ADULT AND FETAL TISSUES
    PRESS, MF
    CORDONCARDO, C
    SLAMON, DJ
    ONCOGENE, 1990, 5 (07) : 953 - 962
  • [46] Isolation of a Novel Nanobody Against HER-2/neu Using Phage Displays Technology
    Sheikholeslami, Farzaneh
    Rasaee, Mohammad J.
    Shokrgozar, Mohammad A.
    Dizaji, Manijeh Mokhtari
    Rahbarizadeh, Fatemeh
    Ahmadvande, Davoud
    LABMEDICINE, 2010, 41 (02): : 69 - 76
  • [47] Control of tumor growth in normal and transgenic mice by listeria monocytogenes based vaccines for HER-2/neu and the identification of regions of HER-2/neu with cryptic CD8+T cell epitopes
    Paterson, Y
    Singh, R
    Jaffee, EM
    Dominiecki, ME
    FASEB JOURNAL, 2005, 19 (04): : A40 - A40
  • [48] TRK-A, HER-2/neu, and KIT Expression/Activation Profiles in Salivary Gland Carcinoma
    Negri, Tiziana
    Tamborini, Elena
    Dagrada, Gian Paolo
    Greco, Angela
    Staurengo, Samantha
    Guzzo, Marco
    Locati, Laura D.
    Carbone, Antonino
    Pierotti, Marco A.
    Licitra, Lisa
    Pilotti, Silvana
    TRANSLATIONAL ONCOLOGY, 2008, 1 (03): : 121 - 128
  • [49] Peptide vaccines of the HER-2/neu dimerization loop are effective in inhibiting mammary tumor growth in vivo
    Allen, Stephanie D.
    Garrett, Joan T.
    Rawale, Sharad V.
    Jones, Audra L.
    Phillips, Gary
    Forni, Guido
    Morris, John C.
    Oshima, Robert G.
    Kaumaya, Pravin T. P.
    JOURNAL OF IMMUNOLOGY, 2007, 179 (01): : 472 - 482
  • [50] Human Epidermal Growth Factor Receptor 2 (HER-2/neu)-Directed Therapy for Rare Metastatic Epithelial Tumors with HER-2 Amplification
    Shin, Daniel Sanghoon
    Sherry, Timothy
    Kallen, Michael E.
    Wong, Steven
    Drakakia, Alexandra
    CASE REPORTS IN ONCOLOGY, 2016, 9 (02): : 298 - 304
12345